<DOC>
	<DOCNO>NCT02310542</DOCNO>
	<brief_summary>A critical issue clinical syndrome liver failure accumulation toxin clear fail liver . Based hypothesis , albumin dialysis use remove substance . Albumin dialysis recirculation ( MARS ) use system require specific system expert environment . Alternative system without recirculation ( SPAD ) less expensive realise critical care service train extrarenal epuration . The primary objective study compare biological clinical efficacy , pulsatility index middle cerebral artery modification tolerance system . This prospective , open , cross-over comparative study two albumin dialysis system . Each patient receive two system randomly assess order . Patients divide accord bilirubin plasmatic level . ( 250µmol/L 400 µmol/L &gt; 400µmol/L ) .</brief_summary>
	<brief_title>Comparison Two Liver Dialysis Systems : MARS Versus SPAD Severe Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<criteria>severe hepatic failure acute liver failure acute chronic liver failure hyperbilirubinemia ( total plasmatic bilirubin level 250µmol/L ) hepatic encephalopathy pruritus hepatorenal syndrome . wait liver function recovery liver transplantation Signed write informed consent patient patient 's legally appoint representative reliable person affiliation social security contraindication extrarenal epuration hypersensibility albumin excipients patient 2 albumin dialysis treatment consider</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>